| Mentor | Area of Research | Research Description |
|---|---|---|
| Edwin Charlebois, PhD, MPH | Basic and Translational Science | Prevention, epidemiology, testing, treatment policy, combination prevention, implementation science, surveillance, tuberculosis co-infection |
| John Gross, PhD | Basic and Translational Science | HIV-1, HIV-2, cellular restriction factors and viral antagonists, genetic conflicts, viral evolution, structural biology, drug discovery |
| Timothy Henrich, MD | Basic and Translational Science | Viral Persistence, HIV-1, SARS-CoV-2, Human Herpes Viruses, Viral Reservoirs, HIV Cure, Translational Virology, Infectious Diseases, Viral-Host Interactions, Single-Cell Analysis, Post-Acute Sequelae, Molecular Imaging, PET imaging, Infectious Disease Molecular Imaging, Digital Spatial Analyses |
| Peter Hunt, MD | Basic and Translational Science | Inflammation, HIV, CMV, Aging, Comorbidities, Translational Research |
| Philip Norris, MD | Basic and Translational Science | Viral, Blood Preservation, Transfusions, Molecular Biology, Isoantibodies, West Nile Faver, HIV Core Protein p24 |
| Melanie Ott, MD, PhD | Basic and Translational Science | HIV-1 cure, latency, and viral reservoirs; HIV transcription and epigenetic regulation; CRISPR/Cas diagnostics; human organoids (airway, gut, brain) and animal models for viral diseases; SARS-CoV-2 and post-acute COVID / long COVID; virus–host protein interaction networks; bunyaviruses |
| Michael Peluso, MD, MPhil, MHS | Basic and Translational Science | HIV cure, HIV clinical trials, Clinical Research, Translational research, COVID-19, Post-acute sequelae of COVID-19 (PASC), Long COVID, Viral persistence |
| Satish Pillai, PhD | Basic and Translational Science | HIV Evolution, Pathogenesis, Persistence, Cell-Intrinsic Immunity, Interferon-alpha, Viral Disease Biomarkers, Cell-free DNA |
| Nadia Roan, PhD | Basic and Translational Science | HIV persistence, Immunity, T cells, single-cell "omics", COVID-19, Women's Health, Mucosa |
| Rachel Rutishauser, MD, PhD | Basic and Translational Science | HIV cure, HIV immunotherapy, CD8+ T cell biology, Vaccines |
| Carol Camlin, PhD, MPH | Behavioral Science | HIV prevention and treatment, Global health, Qualitative and mixed methods research, Human mobility and migration, Social networks and network-based interventions, Behavioral and social science research, Gender and sexual & reproductive health, Sub-Saharan Africa / East Africa |
| Amy Conroy, PhD, MPH | Behavioral Science | Dyadic health; couple-based interventions; alcohol use; cardiometabolic disorders; multimorbidity; perinatal depression; mental health; HIV treatment engagement; global health |
| Orlando Harris, PhD, RN, FNP, MPH | Behavioral Science | Sexual and Gender Minority Health, Healthy Equity, Syndemic Policy Research, Community engagement, Mixed-methods research, Caribbean Sexualities |
| Mallory Johnson, PhD | Behavioral Science | HIV Infections, Anti-HIV Agents, Sexual Partners, Patient Compliance, Medication Adherence, Mentoring Junior Faculty |
| Julia Lechuga, PhD | Behavioral Science | Latinx populations, Health disparities, Behavioral interventions, Culturally tailored interventions, Community-based participatory research (CBPR), Social & cultural determinants of health, Community partnerships |
| Sheri Lippman, PhD, MPH | Behavioral Science | Community engagement/ community mobilization, Social-structural interventions, Implementation science, International prevention and care research (South Africa / Brazil), Self-testing and point-of-care testing, Social determinants of health / social epidemiology |
| Ali Mirzazadeh, MD, PhD | Behavioral Science | Epidemiology, Hard-to-reach/underserved populations, Sampling & recruitment methods, Respondent-driven sampling, Population size estimation, Survey methods, Sampling & selection bias, Measurement bias, Representativeness |
| Jerry Ouner, PhD, RN, MS | Behavioral Science | Water insecurity, extreme weather events and HIV treatment outcomes, Antiretroviral therapy (ART) adherence , HIV/AIDS and maternal and child health, HIV treatment and prevention, Prevention of mother-to-child transmission (PMTCT), HIV-related stigma |
| Kartika Palar, PhD, MA | Behavioral Science | Health equity, HIV/NCD comorbidities, Food security, Social determinants of health, Community-based interventions, Mixed methods, Health policy, Latin America and the Caribbean |
| Jesús Ramírez-Valles, PhD, MPH | Behavioral Science | LGBTQ health, public health, HIV, stigma, racism, Latin American, aging, Latinx populations |
| Greg Rebchook, PhD | Behavioral Science | Implementation Science, MSM, Trans communities, community engaged research, translating research into practice, intervention development and evaluation, capacity building assistance, implementation/replication Manuals, community-level interventions |
| Milo Santos, PhD, MPH | Behavioral Science | HIV/AIDS, Implementation science, Substance abuse |
| John Sauceda, PhD, MSc, MA | Behavioral Science | HIV treatment and engagement research; intervention science; psychometrics; mental health and substance use research; Latino health |
| Wayne Steward, PhD, MPH | Behavioral Science | HIV policy research, health services research, implementation science, stigma measurement and intervention, use of AI to improve engagement in care, global health |
| Paul Wesson, PhD | Behavioral Science | HIV, hidden populations, hard-to-reach populations, sampling, population size estimation, criminal legal involvement, causal inference, intersectionality |
| Erin Wilson, DrPH, MPH | Behavioral Science | Social Epidemiology, Health Disparities research focused on sexual and gender minority groups with intersecting substance use and mental health needs, Syndemic Theory & Co-Occurring Risks, Intersectionality & Structural Stigma, Intervention strategies (Randomized Controlled Trials (RCTs) & Demonstration Projects), Status Neutral, HIV care and PrEP interventions, Digital Health & Mobile Health (mHealth), Multi-level Interventions, Community-based research and interventions, Implementation Science, Regions: San Francisco, Louisiana, Brazil, Nepal |
| Emily Arnold, PhD | Clinical & Epidemiological Science | Ethnography, Qualitative Methods, Social Networks, Social Support, Children/youth, Socioeconomically marginalized groups, LGBT populations, Clinic, Intervention Development, Community-based collaborative research, Policy advocacy, HIV, Implementation Science, Interdisciplinary research collaboration |
| Francesca Aweeka, PharmD | Clinical & Epidemiological Science | Analytical techniques for quantification of HIV, malaria, Antimalarials,TB and Oncology Drugs in Plasma |
| Susan Buchbinder, MD | Clinical & Epidemiological Science | Public Health, Director Bridge HIV, HIV Prevention, HIV Transmission, Epidemiology and Biostatistics, Mentoring Junior Faculty |
| Gabriel Chamie, MD | Clinical & Epidemiological Science | HIV, TB, unhealthy alcohol use, Kenya, Uganda, rural populations |
| Phillip Coffin, MD, MIA | Clinical & Epidemiological Science | Public Health Research, Infectious Disease, HIV, HIV Risk Behavior, Addiction Management, Substance Abuse, Drug Users, Overdose Prevention, Clinical Trials, Toxicology, Viral Hepatitis Care |
| Craig Cohen, MD, MPH | Clinical & Epidemiological Science | Reproductive health, global health, clinical trials, vaginal microbiome, STIs |
| Carol Dawson-Rose, RN, PhD, FAAN | Clinical & Epidemiological Science | Implementation Science, HIV Infectious, Qualitative Research Methods, Socio-Economically Marginalized groups; Social Stigma, Counseling, Mentoring Junior Faculty |
| Steven Deeks, MD | Clinical & Epidemiological Science | HIV Cure, CD4-Positive T-lymphocytes, HIV-1, HIV Infections, Anti-HIV agents, Antiretroviral Therapy, Highly Active |
| Elizabeth Fair, MD, PhD | Clinical & Epidemiological Science | Tuberculosis, Urban health, Contact tracing |
| Jonathan Fuchs, MD, MPH | Clinical & Epidemiological Science | Public Health, HIV, HIV Prevention, STD, HIV Immunology, HIV Vaccine, Mentoring Junior Faculty |
| Monica Gandhi, MD, MPH | Clinical & Epidemiological Science | Hair, HIV Infections, Anti-HIV Agents, Nevirapine, Bonzoxazines, Mentoring Junior Faculty |
| Judy Hahn, PhD, MA | Clinical & Epidemiological Science | Alcohol drinking, Hepatitis C, Uganda, Substance Abuse, Intravenous, Epidemiology, Infectious Disease |
| Laurence Huang, MD | Clinical & Epidemiological Science | HIV-associated pulmonary diseases, Post-TB lung disease, Global lung health |
| Vivek Jain, MD, MAS | Clinical & Epidemiological Science | HIV, Infectious diseases, respiratory viral infections, implementation science, HIV clinical care, antiretroviral therapy, care delivery models |
| Jenny Liu, PhD, MPP, MA | Clinical & Epidemiological Science | Child & adolescent health, Epidemiology & surveillance, Reproductive health, Health economics, HIV/AIDS, Implementation science, Primary care, Women's health, consumer health markets, human-centered design, behavioral sciences |
| Albert Liu, MD, MPH | Clinical & Epidemiological Science | PrEP, Long-acting PrEP, Mobile app interventions, STI testing, Methamphetamine use, Public health, Implementation science, Injection modalities, Safety-net clinics |
| Annie Luetkemeyer, MD | Clinical & Epidemiological Science | ACTG, Clinical Trials, Antitubercular Agents, Antiviral Agents, Rifampin, TB, HIV Infections |
| Jeffrey Martin, MD, MPH | Clinical & Epidemiological Science | Epi, DB Research, Sarcoma, Kaposi, HIV-1, HIV Infections, Anti-HIV agents, Antiretroviral Therapy, East Africa |
| Torsten Neilands, PhD | Clinical & Epidemiological Science | Applied data analysis, survey scale development & validation; latent variable modeling (e.g., factor analysis, structural equation modeling), longitudinal analysis with random effects, addressing missing data |
| Jennifer Price, MD, PhD | Clinical & Epidemiological Science | Liver disease, Hepatitis C virus, Hepatitis B virus, Hepatic steatosis |
| Elise Riley, PhD | Clinical & Epidemiological Science | Co-occurring conditions, cardiovascular complications, cerebrovascular complications, stimulant use, polysubstance use, integrated care |
| Parya Saberi, PharmD | Clinical & Epidemiological Science | Medication adherence, technology, mobile health, remote research, non-clinical settings, home-based care, pharmacy, pre-exposure prophylaxis, long-acting injectables, artificial intelligence, psychedelics |
| Matthew Spinelli, MD, MAS | Clinical & Epidemiological Science | PrEP, HIV prevention, implementation science, infectious diseases |
| Phyllis Tien, MD | Clinical & Epidemiological Science | HIV infections, Infectious Diseases, Viral Hepatitis, Antiretroviral Therapy, Co-infection, Co-morbidities, Ovarian aging, and MACS/WIHS Combined Cohort Study (MWCCS) |
| Sheri Weiser, MD | Clinical & Epidemiological Science | HIV Infections, Food Supply, Homeless Persons, ART, Medication Adherence, Social Stigma, Sub-Saharan Africa |
Contacts
Joe Watabe, MS
CFAR Developmental Core Manager

















































